Prolactin Hormone in Rheumatoid Arthritis Patients With Periodontitis

Sponsor
October University for Modern Sciences and Arts (Other)
Overall Status
Unknown status
CT.gov ID
NCT04279691
Collaborator
(none)
30
1

Study Details

Study Description

Brief Summary

In this study we will assess the presence of prolactin hormone in the gingival crevicular fluid , and synovial fluid of patient with rheumatoid arthritis and periodontitis

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Synovial and Gingival Crevicular Fluid Levels of Prolactin Hormone in Rheumatoid Arthritis Patients With Periodontitis
    Anticipated Study Start Date :
    Mar 1, 2020
    Anticipated Primary Completion Date :
    Apr 1, 2020
    Anticipated Study Completion Date :
    Apr 1, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    periodontitis and rheumatoid arthritis

    group 1: patiernts with periodontitis and rheumatoid arthritis. only

    periodontitis

    group 2: patiernts with periodontitis

    Outcome Measures

    Primary Outcome Measures

    1. prolactin hormone levels in the tested media [24 hours]

      changes in prolactin hormone expression in the tested media

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • for first group patients with active rheumatoid arthritis with periodontitis.

    • second group , patients with periodontitis and otherwise systemically healthy

    • third group, systemically and periodontallly healthy subjects

    Exclusion Criteria:
    • smokers,

    • pregnant or lactating females

    • patients taking medications the affects levels of prolactin hormone.

    • no periodontal treatment in the past six months

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • October University for Modern Sciences and Arts

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Naglaa Elwakeel, professor, October University for Modern Sciences and Arts
    ClinicalTrials.gov Identifier:
    NCT04279691
    Other Study ID Numbers:
    • ETH14
    First Posted:
    Feb 21, 2020
    Last Update Posted:
    Feb 21, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 21, 2020